184 related articles for article (PubMed ID: 23674172)
1. Identification of circulating microRNAs in HNF1A-MODY carriers.
Bonner C; Nyhan KC; Bacon S; Kyithar MP; Schmid J; Concannon CG; Bray IM; Stallings RL; Prehn JH; Byrne MM
Diabetologia; 2013 Aug; 56(8):1743-51. PubMed ID: 23674172
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation.
Bonner C; Farrelly AM; Concannon CG; Dussmann H; Baquié M; Virard I; Wobser H; Kögel D; Wollheim CB; Rupnik M; Byrne MM; König HG; Prehn JH
J Biol Chem; 2011 Jul; 286(29):25719-28. PubMed ID: 21628466
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors.
Fendler W; Madzio J; Kozinski K; Patel K; Janikiewicz J; Szopa M; Tracz A; Borowiec M; Jarosz-Chobot P; Mysliwiec M; Szadkowska A; Hattersley AT; Ellard S; Malecki MT; Dobrzyn A; Mlynarski W
Diabetologia; 2016 Jul; 59(7):1463-1473. PubMed ID: 27059371
[TBL] [Abstract][Full Text] [Related]
4. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.
Bonner C; Bacon S; Concannon CG; Rizvi SR; Baquié M; Farrelly AM; Kilbride SM; Dussmann H; Ward MW; Boulanger CM; Wollheim CB; Graf R; Byrne MM; Prehn JH
Diabetes; 2010 Nov; 59(11):2799-808. PubMed ID: 20682686
[TBL] [Abstract][Full Text] [Related]
5. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
[TBL] [Abstract][Full Text] [Related]
6. Circulating CD36 is reduced in HNF1A-MODY carriers.
Bacon S; Kyithar MP; Schmid J; Costa Pozza A; Handberg A; Byrne MM
PLoS One; 2013; 8(9):e74577. PubMed ID: 24069322
[TBL] [Abstract][Full Text] [Related]
7. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
[TBL] [Abstract][Full Text] [Related]
8. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
9. Molecular background and clinical characteristics of HNF1A MODY in a Polish population.
Skupien J; Gorczynska-Kosiorz S; Klupa T; Cyganek K; Wanic K; Borowiec M; Sieradzki J; Malecki MT
Diabetes Metab; 2008 Nov; 34(5):524-8. PubMed ID: 18838325
[TBL] [Abstract][Full Text] [Related]
10. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
[TBL] [Abstract][Full Text] [Related]
11. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes.
Svalastoga P; Kaci A; Molnes J; Solheim MH; Johansson BB; Krogvold L; Skrivarhaug T; Valen E; Johansson S; Molven A; Sagen JV; Søfteland E; Bjørkhaug L; Tjora E; Aukrust I; Njølstad PR
Diabetologia; 2023 Dec; 66(12):2226-2237. PubMed ID: 37798422
[TBL] [Abstract][Full Text] [Related]
13. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
Kettunen JLT; Rantala E; Dwivedi OP; Isomaa B; Sarelin L; Kokko P; Hakaste L; Miettinen PJ; Groop LC; Tuomi T
Diabetologia; 2022 Apr; 65(4):632-643. PubMed ID: 34951657
[TBL] [Abstract][Full Text] [Related]
14. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into genetics and clinics of the HNF1A-MODY.
Valkovicova T; Skopkova M; Stanik J; Gasperikova D
Endocr Regul; 2019 Apr; 53(2):110-134. PubMed ID: 31517624
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
Farrelly AM; Kilbride SM; Bonner C; Prehn JH; Byrne MM
Apoptosis; 2011 Nov; 16(11):1128-37. PubMed ID: 21874357
[TBL] [Abstract][Full Text] [Related]
17. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
Szopa M; Klupa T; Kapusta M; Matejko B; Ucieklak D; Glodzik W; Zapala B; Sani CM; Hohendorff J; Malecki MT; Skupien J
Endocrine; 2019 Apr; 64(1):75-81. PubMed ID: 30778899
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessment in patients with HNF1A-MODY and GCK-MODY.
Szopa M; Matejko B; Ucieklak D; Uchman A; Hohendorff J; Mrozińska S; Głodzik W; Zapała B; Płatek T; Solecka I; Sani CM; Małecki MT
Endocrine; 2019 May; 64(2):246-253. PubMed ID: 30421137
[TBL] [Abstract][Full Text] [Related]
19. Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 Diabetes.
Huang X; Gong S; Ma Y; Cai X; Zhou L; Luo Y; Li M; Liu W; Zhang S; Zhang X; Ren Q; Zhu Y; Zhou X; Zhang R; Chen L; Gao X; Zhang F; Wang Y; Han X; Ji L
J Diabetes Res; 2018; 2018():7842064. PubMed ID: 30155490
[TBL] [Abstract][Full Text] [Related]
20. Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database.
Awa WL; Thon A; Raile K; Grulich-Henn J; Meissner T; Schober E; Holl RW;
Eur J Endocrinol; 2011 Apr; 164(4):513-20. PubMed ID: 21224407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]